Skip to main content
ARQT
NASDAQ Life Sciences

Health Canada Approves Arcutis' Przoryve Cream for Young Children with Atopic Dermatitis

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$24.92
Mkt Cap
$3.132B
52W Low
$15.1
52W High
$31.77
52W Position info
65% above low
Off High info
22% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

ARQT sits 65% above its 52-week low of $15.1.

Summary

Health Canada approved Przoryve cream 0.05% for children aged 2 to 5 years with mild to moderate atopic dermatitis. This expands the product's label into a new geography and a younger pediatric population. The approval follows the FDA's acceptance of a supplemental New Drug Application for ZORYVE cream 0.05% in July, indicating a broader regulatory push for the franchise. Arcutis reported strong Q2 results with product revenue up 59% year-over-year, driven by ZORYVE sales. This Canadian approval adds another revenue stream and validates the product's safety and efficacy in a vulnerable age group.

At the time of this announcement, ARQT was trading at $24.92 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.1B. The 52-week trading range was $15.10 to $31.77. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

ARQT - Latest Insights

ARQT
Nov 05, 2026, 11:52 AM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $26.96
Real-time Price: $27.61 info
Change: +$0.650 (+2%) info
Market Cap: $3.491B info
ARQT
Nov 05, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $29.00
Real-time Price: $27.61 info
Change: -$1.39 (-5%) info
Market Cap: $3.491B info
ARQT
Nov 04, 2026, 4:04 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $31.25
Real-time Price: $27.61 info
Change: -$3.64 (-12%) info
Market Cap: $3.491B info
ARQT
Nov 04, 2026, 4:02 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $32.30
Real-time Price: $27.61 info
Change: -$4.69 (-15%) info
Market Cap: $3.491B info
ARQT
Nov 04, 2026, 4:00 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $34.23
Real-time Price: $27.61 info
Change: -$6.62 (-19%) info
Market Cap: $3.491B info